Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 269,630	$ 1,123,843
Short-term investments	100,811	104,870
Accounts receivable, net	245,736	241,931
Prepaid expenses	19,447	16,898
Income taxes receivable	19,393	0
Other current assets	10,382	61,806
Total current assets	665,399	1,549,348
Property and equipment, net	80,805	76,191
Goodwill	1,482,497	1,477,968
Intangible assets, net	21,483	26,642
Operating and finance lease right-of-use assets	52,634	55,972
Deferred income tax assets	70,868	54,472
Other assets	110,058	107,355
Total assets	2,483,744	3,347,948
Current liabilities:
Accounts payable and accrued expenses	306,410	423,183
Current portion of finance lease liabilities	2,369	2,219
Current portion of operating lease liabilities	18,179	18,933
Total current liabilities	326,958	444,335
Long-term debt and finance lease liabilities, net	996,862	1,742,586
Long-term operating lease liabilities	37,857	40,970
Long-term professional liabilities	267,215	265,274
Deferred income tax liabilities	61,746	61,746
Other liabilities	26,123	45,320
Total liabilities	1,716,761	2,600,231
Commitments and contingencies
Shareholders' equity:
Preferred stock; $.01 par value; 1,000 shares authorized; none issued	0	0
Common stock; $.01 par value; 200,000 shares authorized; 86,210 and 85,593 shares issued and outstanding, respectively	862	856
Additional paid-in capital	1,032,212	1,029,453
Accumulated other comprehensive income	2,397	3,530
Retained deficit	(268,712)	(286,354)
Total Mednax, Inc. shareholders' equity	766,759	747,485
Noncontrolling interest	224	232
Total equity	766,983	747,717
Total liabilities and equity	$ 2,483,744	$ 3,347,948